Watch Ticker

Capricor Therapeutics Inc

Go to Capricor Therapeutics Inc Website

$7.67

0.00 (0.00%)

Live

Previous Close

$7.67

Day Range

$0 - $0

Previous Day Range

$7.351 - $7.79

Market Cap

$351.0 million USD

Day Vol.

Previous Day Vol.

984589

Currency

USD

Primary Exchange

Nasdaq

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Bragar Eagel & Squire, P.C. - Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits

Law firm Bragar Eagel & Squire announces class action lawsuits against XPLR Infrastructure, Centene, Biohaven, and Capricor Therapeutics for alleged misleading statements and financial misrepresentations.

Related tickers: XIFR, CNC, BHVN, CAPR.

Read Full Article

Rosen Law Firm - ROSEN, A LEADING NATIONAL FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR

Rosen Law Firm alerts Capricor Therapeutics investors about a securities class action lawsuit regarding potentially misleading statements about deramiocel's safety and efficacy data during the period of October 9, 2024 to July 10, 2025.

Related tickers: CAPR.

Read Full Article

Trending Tickers

Please sign in to view